Fig. 5From: Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRIThe bar charts of HER2, TUNEL, E-cadherin, VMI and CD31 quantifications in the four groups at the end of treatment. VMI, vessel maturity index; HER2, human epidermal growth Factor 2; TUNEL, terminal-deoxynucleotidyl transferase mediated nick end labellingBack to article page